https://mpxbioceutical.com/ Editor's note: Canadian Bioceutical Corp is now called MPX Bioceutical Corporation, and previous symbol BCC on Venture Exchange is now MPX on the CSE ( thecse.com ) and MPXEF on OTC ( otcmarkets.com ) CURRENT HOLDINGS, BRANDS, AND INVOLVEMENT AS OF DEC. 24 2017
: Cultivation, Production, and Distribution with our acquisition of GreenMart of Nevada LLC
: Cultivation facility, 2 Health for Life (‘H4L’) Dispensaries, now adding a third dispensary, and its well established MPX Brand
: Wholly-owned subsidiary CGX Life Sciences Inc. has a 51% interest in IMT LLC and Fall River Developments, LLC (“FRD”), two Massachusetts registered companies active in the cannabis space
: MPX Bioceutical Corporation has entered into non-binding letters of intent to acquire dispensary and production licenses in Maryland
: MPX Bioceutical Corporation is developing a 72,342 square foot production facility in Owen Sound, Ontario. Future expansion allows for up to an additional 402,658 square feet for a total of 475,000 square feet
- MELTING POINT EXTRACTS
: MPX brands utilize state of the art extraction equipment and exceptional starting materials to provide best-in-class award winning products, currently offered in Arizona, Nevada and Massachusetts.
- SALUS BIOPHARMA
: MPX Bioceutical Corporation has entered into a binding term sheet to create a joint venture with Panaxia
to develop proprietary, smokeless pharma-grade products using cannabis under the Salus BioPharma brand. CEO Scott Boyes speaks to Canada's Business News Network in Toronto:
https://www.bnn.ca/commodities/video/canada-lost-headstart-in-cannabis-market-canadian-bioceutical-ceo~1155698 Nevada acquisition highlights
Creates strong presence in Las Vegas adult use market with over 42 million visitors annually.
Existing licensees have 12-18 month headstart to establish market share.
Fully operational, fully staffed, state-of-the-art licensed production facility, with capacity to produce 1.6 million grams of dried flower and 85,000 grams of high-margin concentrate.
Operations include production of concentrates, as well as edible and other high-margin infused products.
Company has commenced selling wholesale into the Nevada medical cannabis market, as well as is applying for a dispensary license to enter the higher-margin retail market.
2016 Jack Herrer Cup winner for best hybrid concentrate.
Arcview Market Research projects annual legal cannabis sales in Nevada to grow to an estimated US$630 million by 2020.
Attractive valuation at $19 million:
$9.5 million, non-interest bearing promissory note
$9.5 million in units, each unit, priced at CAD$0.75 Management commentary
“Commencement of sales into the adult use market in Nevada, under the state’s “Early Start Capitalized” program, is anticipated for July of this year, with a 12-18-month early mover advantage for existing licensees,” stated Scott Boyes, CEO. “In order to benefit from the strong revenue and cash flow growth anticipated for GreenMart, we decided to accelerate exercising our option and acquire the company. We anticipate the operations to be materially accretive for revenues and earnings in the current fiscal year. We are delighted to bring GreenMart and its award winning products under the BCC umbrella, and we look forward to reporting on our progress as we continue to execute on our aggressive growth strategy.”
GreenMart is fully staffed and operational, and is extremely well-managed. In developing the Nevada business, we are leveraging the operational and commercial best practices developed at our highly successful Health for Life and MPX brands in Arizona. We anticipate this will accelerate market share development in a potentially very sizeable market with strong barriers to entry. Additionally, the shared operational template facilitates integration. READ THE FULL NEVADA ACQUISITION ARTICLE HERE:
https://www.newcannabisventures.com/nevada-cannabis-operations-to-be-acquired-for-19mm-by-canadian-public-company/ MPX PRESENTATION TO INVESTORS: http://mpxbioceutical.com/wp-content/uploads/2017/12/171106-MPX-Presentation-FINAL-VERSION.pdf